OssDsign has appointed Stephen Anderson as Vice President of Marketing

Stephen Anderson has over 25 years of global experience in marketing, sales, and engineering in the medical device industry. He has held various senior roles, including Senior Vice President of Sales and Marketing at Sharp Fluidics, Vice President of Sales and Marketing at NeoSurgical, Senior Director of Marketing at Invuity, and Global Director of Marketing at Zimmer Spine. In addition to these positions, he has also undertaken several advisory roles. Stephen Anderson will be based in the U.S. and holds a Bachelor of Science in Mechanical Engineering from the University of Massachusetts and a Master of Science in Management Sciences from Northeastern University.

”The recruitment of Stephen is in line with our strategy to enhance our presence in the U.S. market, and we are delighted to welcome him onboard. With his extensive experience in sales and marketing within the MedTech industry, he will be an invaluable asset in our future endeavors”, said Morten Henneveld, CEO of OssDsign

For further information, please contact:

Morten Henneveld, CEO, OssDsign AB

Tel: +46 73 382 43 90, email: [email protected]

About OssDsign

OssDsign is a developer and global provider of next generation orthobiologics products. Based on cutting edge material science, the company develops and markets products that support the body’s own healing capabilities, giving patients back the life they deserve. OssDsign’s share is traded on Nasdaq First North Growth Market in Stockholm, Sweden. The Company’s Certified Adviser is Carnegie Investment Bank AB (publ).

For further information, please contact:

Morten Henneveld, CEO, OssDsign AB
Tel: +46 73 382 43 90, email: [email protected]

Certified Adviser

The Company’s Certified Adviser is Carnegie Investment Bank AB (publ)

About OssDsign

OssDsign is a developer and global provider of next generation bone replacement products. Based on cutting edge material science, the company develops and markets products that support the body’s own healing capabilities and thereby improve the clinical outcome in a wide range of orthopedic areas with high medical needs. With a product portfolio consisting of patient-specific implants for cranial surgeries and an off-the-shelf synthetic bone graft for spine surgeries, OssDsign give patients back the life they deserve. The company has a strong commercial presence in the U.S., Europe and selected Asian countries. OssDsign’s share is traded on Nasdaq First North Growth Market in Stockholm, Sweden.